When a medical device is recalled, the “why,” in the most general terms, is obvious—something is defective. But new research further examines what goes into recall decisions, finding product managers often rely on physicians to find problems with devices. Additionally, device suppliers can be less likely to issue a recall until the cause of the defect is discovered, which can reduce recall costs.

When compared to an FDA-regulated baby monitor, two smartphone-integrated consumer monitors performed inconsistently and displayed incorrectly low pulse rates, according to a Aug. 21 research letter published in JAMA.

An app designed to help those recovering from breast cancer was recently honored by the National Lottery Awards in the United Kingdom.

Most hospital executives and directors—nearly three in every five—believe Amazon will have the biggest impact in the healthcare market, according to a survey conducted by Reaction Data.

Researchers from Purdue University in West Lafayette, Indiana, is working to develop a new type 1 diabetes therapy that may lead to the long-term reversal of the disease in humans—and man's best friend.

SOC Telemed, the nation’s largest national provider of telemedicine technology to healthcare providers, has acquired behavioral health telemedicine company JSA Health.

Never has so much data been available—but those in medicine face the ongoing challenge of making the most of what’s available. A new report from Deloitte examined just how medical technology companies can improve outcomes, reduce costs and bolster efficiency.

A research team was able to successfully attack a patient monitoring system to emulate and modify vital signs in real-time.